The Guardian, Thursday 22 June 2017 15.00 AEST When I first heard about the HIV-prevention drug PrEP – pre-exposure prophylaxis – I had mixed feelings. It remains controversial even among readers of the gay magazine Attitude. “Why should my taxes pay for these sluts to have bareback sex?” is a typical comment. But I was worried that my reaction was the result of anti-gay conditioning, being...
22 May 2017 VAC has learned that a person on the Victorian PrEPX study has seroconverted and become HIV positive. There are two ways that this may have occurred. • If a person is not adherent to their PrEP regimen (taking the prescribed dose regularly) it is possible that they would not be protected against acquiring HIV; • If a person comes into contact with a person living with HIV who has...
SAMESH, April 2017 There has been a lot of community interest in the PrEPX-SA trial. You are invited to an upcoming community forum where a distinguished panel of experts and community members involved in the field will discuss PrEP, a powerful new tool to prevent HIV and the upcoming PrEPX-SA study. The panel will include: Associate Professor Edwina Wright (Alfred Health) Professor Steve...
South Australian Health and Medical Research Institute (SAHMRI), Monday, 27 February 2017 South Australians at a high risk of acquiring HIV will have the opportunity to benefit from the latest HIV prevention medication through a new partnership. Following the announcement of the Pre-Exposure Prophylaxis (PrEP) access trial late last year, Victoria’s Alfred Health has been chosen to partner with...
Gay News Network, Wednesday 18 January 2017 The Victorian AIDS Council has announced it will give an additional $100,000 to the PrEPX trial to fund access to pre-exposure prophylaxis for HIV (PrEP) for 600 Victorians at risk. VAC’s announcement comes months after PrEPX reached capacity for men living in metropolitan Melbourne. The VAC said there is already a substantial waiting list for those...